Strides Shasun Ltd - Strides Shasun receives Establishment inspection Report from US FDA for its Oral Dosage Facility at Bangalore

Strides Shasun Ltd has informed BSE that the Company's Oral Dosage Forms manufacturing site (KRS Gardens) in Bangalore which was inspected by the US FDA in February 2016 has received the Establishment Inspection Report (EIR), thereby confirming the closure of the inspection. The facility continues to be US FDA Approved.<BR><BR>The KRS Gardens facility in Bangalore manufactures oral dosage forms including tablets, capsules (both hard gelatine and soft gelatine). The manufacturing plant supports important current and future submissions for the US Market.